|
CAMSAP1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00690000004455E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.16810000000611E-06 |
| Normal-vs-Stage2 |
2.156100E-03 |
| Normal-vs-Stage3 |
1.96450999999653E-05 |
| Normal-vs-Stage4 |
2.569600E-04 |
| Stage1-vs-Stage2 |
6.755400E-01 |
| Stage1-vs-Stage3 |
6.907800E-01 |
| Stage1-vs-Stage4 |
8.019200E-01 |
| Stage2-vs-Stage3 |
5.181600E-01 |
| Stage2-vs-Stage4 |
5.975800E-01 |
| Stage3-vs-Stage4 |
9.629200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59710000002811E-06 |
| Normal-vs-AfricanAmerican |
2.184800E-01 |
| Normal-vs-Asian |
8.11840000000119E-05 |
| Caucasian-vs-AfricanAmerican |
6.415900E-02 |
| Caucasian-vs-Asian |
7.404400E-01 |
| AfricanAmerican-vs-Asian |
5.691800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.92330000043017E-07 |
| Normal-vs-Female |
1.77261999999567E-05 |
| Male-vs-Female |
2.659600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.59159999999692E-05 |
| Normal-vs-Age(41-60Yrs) |
4.56729999998018E-06 |
| Normal-vs-Age(61-80Yrs) |
1.002100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.595610E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.540800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.854200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.421600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.206000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.947600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.886600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.851780E-02 |
| Classical-VS-Follicular |
4.877600E-02 |
| Classical-VS-Other |
1.919980E-01 |
| Classical-VS-Normal |
1.645190E-04 |
| Tall-VS-Follicular |
5.496400E-01 |
| Tall-VS-Other |
7.026400E-01 |
| Tall-VS-Normal |
4.68249999996395E-06 |
| Follicular-VS-Other |
5.287400E-01 |
| Follicular-VS-Normal |
1.52538000000035E-05 |
| Other-VS-Normal |
8.682600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.74799999988984E-07 |
| Normal-vs-N1 |
1.154470E-04 |
| N0-vs-N1 |
9.429200E-01 |
|
|
